1. Home
  2. CAL vs VOGX Comparison

CAL vs VOGX Comparison

Compare CAL & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

N/A

Current Price

$12.21

Market Cap

449.1M

ML Signal

N/A

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$33.75

Market Cap

456.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAL
VOGX
Founded
1878
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
456.5M
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
CAL
VOGX
Price
$12.21
$33.75
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
460.8K
248.8K
Earning Date
05-28-2026
N/A
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$85,513,000.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$2.45
N/A
P/E Ratio
$27.95
N/A
Revenue Growth
0.46
N/A
52 Week Low
$8.80
$14.80
52 Week High
$16.14
$35.50

Technical Indicators

Market Signals
Indicator
CAL
VOGX
Relative Strength Index (RSI) 38.16 95.54
Support Level $11.24 $27.37
Resistance Level $11.92 $34.61
Average True Range (ATR) 0.52 4.45
MACD -0.23 0.98
Stochastic Oscillator 5.65 90.43

Price Performance

Historical Comparison
CAL
VOGX

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: